Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Pharmacokinetics|April 30, 2002
Fomivirsen: clinical pharmacology and potential drug interactionsRichard S Geary, Scott P Henry, Lisa R GrilloneAmerican Journal of Ophthalmology|August 30, 2005
Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhageBaruch D Kuppermann, Edgar L Thomas, Marc D de Smet, et al.American Journal of Ophthalmology|October 18, 2005
Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhageBaruch D Kuppermann, Edgar L Thomas, Marc D de Smet, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 16, 2007
The systemic safety of bromfenac ophthalmic solution 0.09%Robert H Stewart, Lisa R Grillone, Mitchell L Shiffman, et al.Ophthalmology|April 21, 2007
Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammationEric D Donnenfeld, Edward J Holland, Robert H Stewart, et al.Journal of Diabetes Science and Technology|February 11, 2010
Antisense oligonucleotide therapy in diabetic retinopathyPeter Hnik, David S Boyer, Lisa R Grillone, et al.Investigative Ophthalmology & Visual Science|April 29, 2008
Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetesAbdhish R Bhavsar, Lisa R Grillone, Timothy R McNamara, et al.Retina (Philadelphia, Pa.)|October 16, 2004
Evolving guidelines for intravitreous injectionsLloyd P Aiello, Alexander J Brucker, Stanley Chang, et al.Pageof 1